The effects of HMG-CoA reductase inhibitors on disease activity in multiple sclerosis: A systematic review and meta-analysis.
第一作者:
Maria-Ioanna,Stefanou
第一单位:
Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece; Department of Neurology & Stroke, Hertie-Institute for Clinical Brain Research, Eberhard-Karls University of Tübingen, Tübingen, Germany.
作者:
医学主题词
人类(Humans);羟甲基戊二酰基CoA还原酶抑制剂(Hydroxymethylglutaryl-CoA Reductase Inhibitors);干扰素β(Interferon-beta);多发性硬化(Multiple Sclerosis);多发性硬化, 慢性进行性(Multiple Sclerosis, Chronic Progressive);多发性硬化, 复发缓解性(Multiple Sclerosis, Relapsing-Remitting);随机对照试验(主题)(Randomized Controlled Trials as Topic)
DOI
10.1016/j.msard.2021.103395
PMID
35216778
发布时间
2022-05-31
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



